Toll Free: +1 (888) HERB-671
International number: +1 (646) 462-HERB
If you are pregnant or breast-feeding, it’s advised you avoid using it. Also, if you suffer from Down syndrome, it’s advised you avoid using it.
The supplement 5-HTP is considered to be the remedy for anxiety and depression. It’s a herbal anti-depressant, product from the protein building block L- tryptophan, that optimizes your hormoned level the natural way.
5-HTP mainly contains a high concentration in 5-Hydroxytryptophan, an identitical natural formula to your natural amino acid used the nervous system in human body to produce the hormone called serotonin. 5-HTP works in the central nervous system, increasing the production of serotonin, which is actually responsible with our good mood.
Serotoning can affect sleep, sexual behaviour, appetite as well as pain levels. 5-HTP increases the serotoning, which means it can be used for people who suffer from depression, obsesity, insomnia and other conditions. In addition, 5-HTP also contains vitamins C, B6 and B3 which makes it easier for your organism to assimilate the natural amino acid.
5-HTP capsules contain: Zinc, Pyridoxine (Vitamine B6), Niacin (Vitamin B3), Ascorbic Acid (Vitamin C).
There have been concerns that 5-HTP can cause side effects such as heartburn, stomach pain, diarrhea, vomiting, drowsiness, nausea, sexual problems, and muscle problems.
Major
Please avoid using 5-HTP is you are already taking medications for depression (Antidepressant drugs) such as: fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft), amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Tofranil), and others or medications for depression (MAOIs) such as: phenelzine (Nardil), tranylcypromine (Parnate), and others.
Moderate
Please be careful if you are already taking: Carbidopa (Lodosyn), Dextromethorphan (Robitussin DM, and others), Meperidine (Demerol), Pentazocine (Talwin), Tramadol (Ultram).
If you are thinking of taking 5-HTP, please get in touch with your medic so ensure the combination is safe for you.
When choosing the appropriate dose of 5-HTP, there is a number of factors to consider, such as age, health, as well as others. There is no scientific information at this time to advise on a certain dosage. Also, even if this is a natural product, dosages are important as a high dosis may not be safe. Please see the product label which includes exact information on recommended dosis. You can also consult your physician or other healthcare professional to advise you on the dosage that would work best for you.
The supplement 5-HTP is also known as: 5HTP, 5 HTP, 5 Hydroxy-Tryptophan, 5 Hydroxy-Tryptophane, 5-hydroxytryptophan, 5-Hydroxytryptophane, 5-Hydroxy L-Tryptophan, 5-Hydroxy L-Tryptophane, 5-Hydroxy Tryptophan, 5-Hydroxy Tryptophane, 5-L-Hydroxytryptophan, L-5 HTP, L-5 hydroxytryptophan, L-5 Hydroxytryptophane, Oxitriptan.
Preshaw RM, Leavitt D, Hoag G. The dietary supplement 5-hydroxytryptophan and urinary 5-hydroxyindole acetic acid. CMAJ 2008;178:993.
Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. J Clin Psychopharmacol 1987;7:127-37.
Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev 2002;(1):CD003198.
Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201-9.
Nicolodi M, Sicuteri F. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol 1996;398:373-9.
Johnson KL, Klarskov K, Benson LM, et al. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. J Rheumatol 1999;26:2714-7.
Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3.
FDA. Information paper on L-tryptophan and 5-hydroxy-L-tryptophan. Office of Nutritional Products, Labeling, Dietary Supplements. Center for Food Safety and Applied Nutrition. February 2001.
Coleman M. Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome. Neurology 1971;21:911-9.
Ribeiro CA. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. Headache 2000;40:451-6.
Poldinger W, Calanchini B, Schwarz W. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology 1991;24:53-81.
Joly P, Lampert A, Thomine E, et al. Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. J Am Acad Dermatol 1991;25:332-3.
Sternberg EM, Van Woert MH, Young SN, et al. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med 1980;303:782-7.
FDA Talk Paper. Impurities confirmed in dietary supplement 5-hydroxy-L-tryptophan. August 31, 1998.
Meyer JS, Welch KM, Deshmukh VD, et al. Neurotransmitter precursor amino acids in the treatment of multi-infarct dementia and Alzheimer's disease. J Amer Geriat Soc 1977;25:289-98.
Williams A, Goodenberger D, Caline DB, et al. Palatal myoclonus following herpes zoster ameliorated by 5-hydroxytryptophan and carbidopa. Neurology 1978;28:358-9.
Trouillas P, Brudon F, Adeleine P. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan: a double-blind study with quantified data processing. Arch Neurol 1988;45:1217-22.
Kahn RS, Westenberg HG. L-5-hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord 1985;8:197-200.
Cangiano C, Ceci F, Cancino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992;56:863-7.
Sarzi Puttini P, Caruso I. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992;20:182-9.
Coppen A, Whybrow PC, Noguera R, et al. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatr 1972;26:234-41.
Nakajima T, Kudo Y, Kaneko Z. Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug. Folia Psychiatr Neurol Jpn 1978;32:223-30.
Michelson D, Page SW, Casey R, et al. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. J Rheumatol 1994;21:2261-5.
Birdsall TC. 5-Hydroxytryptophan: A Clinically-Effective Serotonin Precursor. Altern Med Rev 1998;3:271-80.
